✨ Free AI Report
Rapid Micro Biosystems, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Rapid Micro Biosystems, Inc.
Company Research

Rapid Micro Biosystems, Inc.: Business Overview, Financials & Competitive Analysis

Rapid Micro Biosystems, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Promising automation market opportunity with improving unit economics, but path to profitability and competitive execution remain key near-term catalysts. RPID shows promising growth trajectory with strong consumables growth and improving margins, but operates unprofitably with negative EBITDA. The company has raised capital via debt financing and demonstrates momentum.

What is Rapid Micro Biosystems, Inc.'s industry? Rapid Micro Biosystems, Inc. (rapidmicrobio.com) operates in Life Sciences Technology / Pharmaceutical Manufacturing Equipment. AskCyborg classifies Rapid Micro Biosystems, Inc. under Life Sciences Technology / Pharmaceutical Manufacturing Equipment in its company registry.

Rapid Micro Biosystems provides mission-critical automation solutions for pharmaceutical manufacturing, with its flagship Growth Direct system automating manual microbial quality control (MQC) testing workflows. The c...

4/ 10Mixed

Cyborg Score thesis

Promising automation market opportunity with improving unit economics, but path to profitability and competitive execution remain...

Read the full analyst-debate transcript →
Industry Life Sciences Technology / Pharmaceutical Manufacturing Equipment
1 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Rapid Micro Biosystems, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Rapid Micro Biosystems, Inc.

AskCyborg analysts argue the bull and bear cases for Rapid Micro Biosystems, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Rapid Micro Biosystems, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Rapid Micro Biosystems, Inc. Overview

Pro stress-test →

Rapid Micro Biosystems provides mission-critical automation solutions for pharmaceutical manufacturing, with its flagship Growth Direct system automating manual microbial quality control (MQC) testing workflows. The company serves critical quality control functions in the manufacturing of biologics, vaccines, cell and gene therapies, and sterile injectables.

Strategic Profile

Pro stress-test →

Rising demand for automated, data-driven microbiology QC and regulatory shifts support strong system placements and recurring consumables revenue, while strategic partnerships and operational efficiencies drive expanded commercial reach and margin expansion. The company operates with a recurring revenue model combining hardware systems with proprietary consumables and software solutions.

Competitive Landscape

Pro stress-test →

RPID operates in the automated microbial testing market for pharmaceutical manufacturing QC. Key competitors include other automation and laboratory testing providers serving pharmaceutical QC needs, though RPID's specialized focus on microbial detection and platform approach provides differentiation. The market benefits from regulatory tailwinds driving adoption of automated solutions.

Industry Context

Rapid Micro Biosystems, Inc. operates in Life Sciences Technology / Pharmaceutical Manufacturing Equipment.

Key facts

Founded: 2006 · Headquarters: Lexington, Massachusetts · Revenue: $33M (2025 guidance) · Market cap: $0.18B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Rapid Micro Biosystems, Inc..

  • Full-year 2025 revenue guidance raised to at least $33 million, driven by strong consumable sales (+40%) and operational efficiencies
  • 174 total systems installed with 152 fully validated, including a multi-system order from a top 20 global biopharma customer in Q3 2025
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Fourth quarter and full year 2025 earnings scheduled for March 12, 2026
  • November 2025Q3 2025 record multi-system customer order from top 20 global biopharma; raised full-year revenue guidance
  • +1 moreTrack every material event for Rapid Micro Biosystems, Inc. as it happens. Explore monitoring →
Get alerted when Rapid Micro Biosystems, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Automated Microbial Testing PlatformsCompeting automation solutions for pharmaceutical quality control→

Compare Rapid Micro Biosystems, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Rapid Micro Biosystems, Inc. operates in Life Sciences Technology / Pharmaceutical Manufacturing Equipment. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences Technology / Pharmaceutical Manufacturing Equipment research →
NEW · MCP server

Ask your AI assistant about Rapid Micro Biosystems, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Rapid Micro Biosystems, Inc. and its top competitor on Cyborg Score”
“What did Rapid Micro Biosystems, Inc. do this quarter?”
“Is Rapid Micro Biosystems, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Rapid Micro Biosystems, Inc. do?+
Rapid Micro Biosystems provides mission-critical automation solutions for pharmaceutical manufacturing, with its flagship Growth Direct system automating manual microbial quality control (MQC) testing workflows. The c...
What is Rapid Micro Biosystems, Inc.'s Cyborg Score?+
Rapid Micro Biosystems, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Rapid Micro Biosystems, Inc.'s main competitors?+
Named competitors include Automated Microbial Testing Platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full Rapid Micro Biosystems, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Rapid Micro Biosystems, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Rapid Micro Biosystems, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Life Sciences Technology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

5Akoya Biosciences, Inc.